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allergy, mucositis, and radiodermatitis) and paraclinical safety (levels of hemoglobin, polynuclear neutrophils and platelets) were
studied.
Results. Induction chemotherapy was better tolerated than that previously reported. The suspension of radiation and hospitaliza-
tion was only observed in one patient (3.5%) during concomitant treatment. The mean dose of radiotherapy administrated over
the tumor bed was 70 Gy 96.5% of patients lost <10% of their body weigth. The incidence of severe hematological toxicity was very
low (9% grade III thrombocytopenia). Radiodermatitis grade I–II occurred in 64% of the patients. No grade III of radiodermatitis
was experienced. 43% of patients presented mucositis grade II, 7% grade III and no grade IV or above was observed. There were
no allergic reactions to cetuximab.
Conclusion. The completed protocol rate for oropharyngeal and hypopharyngeal patients receiving ICT and ERT with concomitant
cetuximab has an acceptable toxicity. Future improvements to protocol will be possible through early action and systematic
implementation of nutritional support coupled with antibiotic treatment upon the ﬁrst signs of radiodermatitis.
http://dx.doi.org/10.1016/j.rpor.2013.03.249
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Introduction and objectives. Functional imaging techniques (PET/CT, MRI) allow us to associate treatment response to delivered
dose quantitatively. We are developing a research project (2012–2014) focused on the quantiﬁcation of tumor response by MRI
and PET/CT.
Material andmethods.We select patientswith locally advancedoropharyngeal tumors, stageT3andT4.All received IMRT treatment
(standard doses of 66Gy). The recording protocol is scheduled as follows: pre-treatment: MRI (1.5T Philips Achieva; single-shot
echo-planar diffusion-weighted MR sequence with different b-values) and PET/CT (PET/CT full body, 370MBq of 18F-FDG, GE
Discovery STE 16unit). First MRI (10–20Gy): diffusion, ADC map. Second MRI (20–50Gy): diffusion, ADC map. 3 Months after
treatment: PET/CT and MRI (diffusion and ADC map). The patients were standing with RT immobilization devices. Only low
distorted slices were analyzed. Were recorded for each patient ADC, SUV, and HU dose per voxel (3mm×3mm×3mm) of each
volume.
Results and discussion. The mean value for ADC and tumor nodules was 1.29×10−3 mm2/s can be set to a Gaussian curve with
a FWHM=0.73×10−3 mm2/s. Using as ﬁlters ADC±FWHM/2, and SUV>1 for the initial ADC and averaged for each volume is
obtained ADC increased with dose for both patients. We see an increase in ADC with increasing dose.
Conclusions. ADC maps can be used for quantifying voxel by voxel the tumor response. The dataset using MRI diffusion and
PET/CT may be useful to identify areas of hypoxia. We recommend the use of the both sets of images to contour the VOI. The
main weakness of this approach is the rigid registration process, so we need new non-rigid registration algorithms for highly
distorted images of diffusion studies. Supported by ISCIII Grant PI11/02035.
http://dx.doi.org/10.1016/j.rpor.2013.03.250
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Introduction. (1) Head and neck tumours synchronous with another tumor in different location are rare and have a poor prognosis
(2-year overall survival 0% if both advanced). (2) Nevertheless, a 33.9% 3-year overall survival has been achieved for selected
patients. (3) When a radiotherapy plan targeting both tumours could be required it is not always feasible since getting acceptable
PTV coverage, without violating OAR constraints, could be difﬁcult. Also, risk of under/overdosing in matching area exists.
Objective. To evaluate the effectiveness of MONACO planner for IMRT treatments in H&N and lung synchronous tumors.
Methods and materials. Two patients diagnosed of a synchronous H&N and lung tumors. Patient 1: base of the tongue cancer
(pTxpN2cM0) and right lower lobe cancer (cT2cN2M0), both squamous cell cancers. Patient 2: glottis squamous cell cancer
(cT4acN1M0) and right upper lobe adenocarcinoma (T3N2M0). Radiotherapy treatment: IMRT with inverse planning and bio-
logical function based optimization obtained with TPS Monaco (CMS/Elekta, Maryland Heights, MO). An static technique type
step and shoot has been employed, and a daily veriﬁcation (kilovoltage cone-beam CT) was performed. Thermoplastic shoulder
mask device+ silicone bite positioner for immobilization were used.
Results. H&N targets. PTV 66: average volumen 137/172 cc; D95>97.8%. PTV 60: average volume: 394.57cc; D95>96%. Parotid
glands: only in one V30>50% (53.6%). Remaining OAR fulﬁlled dose constraints. Lung targets. PTV (60+66): average volume
230.95 cc; D95>97.5%. Esopaghus: V35<46%. Lung: V20<31%.
Conclusions. (1) Biological function based planiﬁcation systems work in all points along the histogram curve obtaining a better
OAR preservation without decreasing excessive the PTV coverage in complex plans. (2) Monaco allows to use only one isocenter
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in these synchronous adjacent tumors, without increasing signiﬁcantly the treatment time. (3) The only technical limitation:
targets larger than 40 cm.
http://dx.doi.org/10.1016/j.rpor.2013.03.251
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Introduction. Branchial cleft cysts (BCC) are a rare entity. Theymay result from the failure of the obliteration of the second branchial
cleft. The proportion of metastatic squamus cell carcinoma (SCC) in cysts initially presumed to be of branchial cleft origin has
been reported to range from 11% to 21%. It is usually presents in the ﬁfth or sixth decades. Lateral cyst masses most often
represent an SCC originating in the epithelium of Waldeyer’s ring-tonsil, tongue base and nasopharynx.
Objective. Treatment with IMRT of squamous cell carcinoma originated on a branchial cyst. Methods: we present a case of a
56-year-old man with a left neck mass lesion in January 2010. The CT scan showed us a superior cervical mass of 21mm (II
level) anteriorly to the jugular vein. In June 2010 our patient underwent complete surgical excision and ipsilateral modiﬁed
radical neck dissection. The histopathologic study reported a squamus cell carcinoma originated on a branchial cyst (3 cm) and
18 lymph nodes free of metastases.
Results. Between Agost 2010 and September 2010 our patient received adyuvant radiotherapy with IMRT technique and integrated
boost. We stablished the following targed volumes: CTV1: tumor bed and CTV2: lymphatyc drainage left levels II, III and IV. We
administred a total dosis of 60Gy to CTV1 and 54Gy to CTV2. The patient presented mucositis grade 1. Twenty-eight months
after the treatment, there was no clinical or radiologic evidence of tumor recurrence.
Conclusion. The management of the branchiogenic squamous cell carcinoma should include extensive excision of tumor and
ipsilateral radical neck dissection to improve the cure rate and survival rate. Adjuvant radiotherapy is recommended to improve
prognosis. IMRT technique enables the target volume to be limited, potentially reducing the ﬁeld of radiation to the radiosensitive
larynx and nasopharynx.
http://dx.doi.org/10.1016/j.rpor.2013.03.252
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Introduction. Helical tomotherapy (HT), an image-guided intensity-modulated radiotherapy technique, allows an accurate target
irradiation while sparing surrounding normal tissue. Objective(s): to evaluate the feasibility of HT in locally advanced nasopha-
ryngeal carcinoma (LANPC) patientswith intracraneal extension and/or involvement of cranial nerves (IVa) or lymphnodes >6 cm
and/or extension to supraclavicular fossa (IVb).
Materials and methods. From August 2009 to January 2013, 17 LANPC patients (IVa stage: 82%; IVb 18%) were treated with HT
and simultaneous integrated boost technique. A median dose of 70Gy to gross tumor volume and positive neck nodes with
margin, 66Gy to high-risk areas and 54Gy to clinically negative neck, in 33 fractions, with concomitant/adjuvant platinum-
based chemotherapy was delivered. Toxicity grading was based on RTOG criteria. Local, locorregional, distant control and overall
survival rates were calculated by using Kaplan–Meier method.
Results. Median follow-up was 16 months (range, 3–36 months). Fifteen complete responses (CR) and 2 partial responses (PR) were
showed. The toxicity RTOG ≥3 was: acute: grade 3: 65% (radiodermatitis n=4, mucositis n=10, aplasia n=1), grade 4: 18% (aplasia:
n=3); late: grade 3: 7.5% (xerostomia: n=3, dysphagia n=1), Grade 4: 0%. Acute/late grade 5 complications were not observed,
but one patient died with brain tissue lesions (recurrence vs necrosis vs abscess not conﬁrmated). The three-year actuarial local,
locorregional and distant control rate were of 93%, 88% and 86% respectively, and a 3-year actuarial progression free survival and
overall survival rate of 63% and 79% respectively. Twelve patients (71%) are alive without disease, 1 patient had local and regional
nodal failure and two patients distant failure (one of them died due to the disease).
Conclusions. HT showed highly conformal dose-avoidance of critical organs while achieving excellent target volume coverage in
regions of highly complex geometry.
http://dx.doi.org/10.1016/j.rpor.2013.03.253
